Addiction and pregnancy

Loretta P. Finnegan, Leslie Amass, Hendree Jones, Karol Kaltenbach

Research output: Contribution to journalArticle

Abstract

Addiction during pregnancy contributes to maternal and infant morbidity including pre-term deliveries, low birth weight, neonatal withdrawal, lengthy neonatal intensive care and infant mortality. Combined use of pharmacological and behavioral treatment approaches in managing pregnant opioid-dependent women has been shown to be beneficial for improving treatment retention and reducing maternal drug use. Clinicians should understand the complex biopsychosocial factors that make the treatment of opioid-dependent pregnant women a challenge as well as the principles and the differences in using methadone or buprenorphine combined with behavioral treatment. Researchers should consider continued studies on the use of methadone during pregnancy, relationship of maternal dose and neonatal abstinence, the differences between methadone and buprenorphine, and the impact of pharmacological options on patients and treatment providers.

Original languageEnglish (US)
Pages (from-to)5-21
Number of pages17
JournalHeroin Addiction and Related Clinical Problems
Volume7
Issue number4
StatePublished - Dec 2005

Fingerprint

Methadone
Pregnancy
Buprenorphine
Mothers
Opioid Analgesics
Pharmacology
Neonatal Intensive Care
Therapeutics
Infant Mortality
Low Birth Weight Infant
Pregnant Women
Research Personnel
Morbidity
Pharmaceutical Preparations

Keywords

  • Addiction
  • Buprenorphine
  • Methadone
  • Pregnancy

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Finnegan, L. P., Amass, L., Jones, H., & Kaltenbach, K. (2005). Addiction and pregnancy. Heroin Addiction and Related Clinical Problems, 7(4), 5-21.

Addiction and pregnancy. / Finnegan, Loretta P.; Amass, Leslie; Jones, Hendree; Kaltenbach, Karol.

In: Heroin Addiction and Related Clinical Problems, Vol. 7, No. 4, 12.2005, p. 5-21.

Research output: Contribution to journalArticle

Finnegan, LP, Amass, L, Jones, H & Kaltenbach, K 2005, 'Addiction and pregnancy', Heroin Addiction and Related Clinical Problems, vol. 7, no. 4, pp. 5-21.
Finnegan LP, Amass L, Jones H, Kaltenbach K. Addiction and pregnancy. Heroin Addiction and Related Clinical Problems. 2005 Dec;7(4):5-21.
Finnegan, Loretta P. ; Amass, Leslie ; Jones, Hendree ; Kaltenbach, Karol. / Addiction and pregnancy. In: Heroin Addiction and Related Clinical Problems. 2005 ; Vol. 7, No. 4. pp. 5-21.
@article{7d14ea2eb63f4483bcf116703c55ef6d,
title = "Addiction and pregnancy",
abstract = "Addiction during pregnancy contributes to maternal and infant morbidity including pre-term deliveries, low birth weight, neonatal withdrawal, lengthy neonatal intensive care and infant mortality. Combined use of pharmacological and behavioral treatment approaches in managing pregnant opioid-dependent women has been shown to be beneficial for improving treatment retention and reducing maternal drug use. Clinicians should understand the complex biopsychosocial factors that make the treatment of opioid-dependent pregnant women a challenge as well as the principles and the differences in using methadone or buprenorphine combined with behavioral treatment. Researchers should consider continued studies on the use of methadone during pregnancy, relationship of maternal dose and neonatal abstinence, the differences between methadone and buprenorphine, and the impact of pharmacological options on patients and treatment providers.",
keywords = "Addiction, Buprenorphine, Methadone, Pregnancy",
author = "Finnegan, {Loretta P.} and Leslie Amass and Hendree Jones and Karol Kaltenbach",
year = "2005",
month = "12",
language = "English (US)",
volume = "7",
pages = "5--21",
journal = "Heroin Addiction and Related Clinical Problems",
issn = "1592-1638",
publisher = "Pacini Editore s.r.l.",
number = "4",

}

TY - JOUR

T1 - Addiction and pregnancy

AU - Finnegan, Loretta P.

AU - Amass, Leslie

AU - Jones, Hendree

AU - Kaltenbach, Karol

PY - 2005/12

Y1 - 2005/12

N2 - Addiction during pregnancy contributes to maternal and infant morbidity including pre-term deliveries, low birth weight, neonatal withdrawal, lengthy neonatal intensive care and infant mortality. Combined use of pharmacological and behavioral treatment approaches in managing pregnant opioid-dependent women has been shown to be beneficial for improving treatment retention and reducing maternal drug use. Clinicians should understand the complex biopsychosocial factors that make the treatment of opioid-dependent pregnant women a challenge as well as the principles and the differences in using methadone or buprenorphine combined with behavioral treatment. Researchers should consider continued studies on the use of methadone during pregnancy, relationship of maternal dose and neonatal abstinence, the differences between methadone and buprenorphine, and the impact of pharmacological options on patients and treatment providers.

AB - Addiction during pregnancy contributes to maternal and infant morbidity including pre-term deliveries, low birth weight, neonatal withdrawal, lengthy neonatal intensive care and infant mortality. Combined use of pharmacological and behavioral treatment approaches in managing pregnant opioid-dependent women has been shown to be beneficial for improving treatment retention and reducing maternal drug use. Clinicians should understand the complex biopsychosocial factors that make the treatment of opioid-dependent pregnant women a challenge as well as the principles and the differences in using methadone or buprenorphine combined with behavioral treatment. Researchers should consider continued studies on the use of methadone during pregnancy, relationship of maternal dose and neonatal abstinence, the differences between methadone and buprenorphine, and the impact of pharmacological options on patients and treatment providers.

KW - Addiction

KW - Buprenorphine

KW - Methadone

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=30444456697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30444456697&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:30444456697

VL - 7

SP - 5

EP - 21

JO - Heroin Addiction and Related Clinical Problems

JF - Heroin Addiction and Related Clinical Problems

SN - 1592-1638

IS - 4

ER -